ST Pharm Co.Ltd (237690) — Free Cash Flow Generation Index
ST Pharm Co.Ltd (237690) has a Free Cash Flow Generation Index of 0.50x as of September 2025. Free cash flow of ₩14.64 Billion represents 1% of operating cash flow (₩29.25 Billion). Explore ST Pharm Co.Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ST Pharm Co.Ltd Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for ST Pharm Co.Ltd across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of ST Pharm Co.Ltd.
Annual Free Cash Flow Generation for ST Pharm Co.Ltd (2015–2025)
Year-by-year Free Cash Flow Generation Index for ST Pharm Co.Ltd. Check 237690 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.38x | ₩-33.30 Billion | ₩13.99 Billion | ₩47.29 Billion | ▼ -1093.3% |
| 2024 | 0.24x | ₩26.23 Billion | ₩109.45 Billion | ₩83.22 Billion | ▲ +100.7% |
| 2023 | -32.46x | ₩-42.14 Billion | ₩1.30 Billion | ₩43.44 Billion | ▼ -325.5% |
| 2022 | -7.63x | ₩-53.63 Billion | ₩7.03 Billion | ₩60.66 Billion | ▼ -24.2% |
| 2021 | -6.14x | ₩-44.65 Billion | ₩7.27 Billion | ₩51.79 Billion | ▼ -274.3% |
| 2018 | 3.52x | ₩37.93 Billion | ₩10.77 Billion | ₩27.17 Billion | ▲ +133.5% |
| 2017 | 1.51x | ₩82.13 Billion | ₩54.44 Billion | ₩27.70 Billion | ▲ +14.7% |
| 2016 | 1.32x | ₩66.81 Billion | ₩50.78 Billion | ₩16.03 Billion | ▼ -19.0% |
| 2015 | 1.63x | ₩58.22 Billion | ₩35.82 Billion | ₩22.40 Billion | — |